0001415889-22-008276.txt : 20220804
0001415889-22-008276.hdr.sgml : 20220804
20220804183146
ACCESSION NUMBER: 0001415889-22-008276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220804
FILED AS OF DATE: 20220804
DATE AS OF CHANGE: 20220804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHON PAUL A
CENTRAL INDEX KEY: 0001231589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 221138123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-08042022_030815.xml
X0306
4
2022-08-04
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231589
MAHON PAUL A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
false
true
false
false
EVP & GENERAL COUNSEL
Common Stock
2022-08-04
4
M
0
4552
111
A
40949
D
Common Stock
2022-08-04
4
S
0
4552
225.81
D
36397
D
Stock Options
111
2022-08-04
4
M
0
4552
0
D
2021-03-15
2028-03-15
Common Stock
4552
0
D
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
John S. Hess, Jr. under Power of Attorney
2022-08-04